ebook img

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment PDF

389 Pages·2007·3.18 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders New Perspectives on Research and Treatment Edited by Michael S. Ritsner Associate Professor, Department of Psychiatry, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa Director, Acute Department, Sha’ar Menashe Mental Health Center, Israel Associate Editor, Quality of Life Research, Amsterdam, The Netherlands and A. George Awad Professor Emeritus, Department of Psychiatry and the Institute of Medical Science University of Toronto Chief of Psychiatry, Humber River Regional Hospital, Toronto, Ontario President, The International Society of CNS Clinical Trials and Methodology, Canada AC.I.P.CataloguerecordforthisbookisavailablefromtheLibraryofCongress. ISBN978-1-4020-5777-9(HB) ISBN978-1-4020-5779-3(e-book) PublishedbySpringer, P.O.Box17,3300AADordrecht,TheNetherlands. www.springer.com Printedonacid-freepaper AllRightsReserved ©2007Springer Nopartofthisworkmaybereproduced,storedinaretrievalsystem,ortransmittedinany formorbyanymeans,electronic,mechanical,photocopying,microfilming,recording orotherwise,withoutwrittenpermissionfromthePublisher,withtheexception ofanymaterialsuppliedspecificallyforthepurposeofbeingenteredandexecuted onacomputersystem,forexclusiveusebythepurchaserofthework. CONTENTS Contributors ix Foreword xiii Part I Key Methodological Issues 1. The Distress/Protection Vulnerability Model of Quality of Life Impairment Syndrome 3 Michael S. Ritsner 2. Role of Dopamine in Pleasure, Reward and Subjective Responses to Drugs 21 Lakshmi N.P. Voruganti and A. George Awad 3. Neuroendocrine Functions, Mood and Quality of Life 33 Marianna Mazza and Salvatore Mazza 4. In the Mind of the Beholder Neuronal Mediators for the Effect of Emotional Experience on Quality of Life 57 Talma Hendler, Roee Admon and David Papo 5. Cross-Cultural Quality of Life Research in Mental Health 67 Monika Bullinger, Silke Schmidt and Dieter Naber 6. Measuring the Value of Health-Related Quality of Life 99 Graeme Hawthorne 7. Comparison of Instruments for Measuring the Quality of Life Impairment Syndrome in Severe Mental Disorders 133 Michael S. Ritsner v vi Contents 8. Integrative Bottom-Up Approach to HRQOL Measurement 143 Ralf Pukrop and Andreas Bechdolf Part II Quality of Life Impairment Syndrome in Severe Mental Disorders 9. Health Related Quality of Life in Subjects at Risk for a First Episode of Psychosis 159 Andreas Bechdolf, Verena Veith, Ralf Pukrop and Joachim Klosterkötter 10. Quality of Life Impairment Syndrome in Schizophrenia 173 Michael S. Ritsner and Anatoly Gibel 11. Insight and Quality of Life in Schizophrenia Spectrum Disorders 227 Paul H. Lysaker and S. Louria 12. Quality of Life and Major Depression 241 Marcelo T. Berlim and Marcelo P.A. Fleck 13. Quality of Life Impairment in Bipolar Disorder 253 Erin E. Michalak Greg Murray Allan H. Young and Raymond W. Lam 14. Quality of Life Impairment in Anxiety Disorders 275 Margaret A. Koury and Mark Hyman Rapaport 15. Quality of Life in Obsessive-Compulsive Disorder 293 Julio Bobes, M.-P. García-Portilla, Maria-Teresa Bascarán, Pilar-Alejandra Sáiz, Maria-Teresa Bobes-Bascarán and Manuel Bousoño Part III Treatment and Rehabilitation Issues 16. Antipsychotic Medications, Schizophrenia and the Issue of Quality of Life 307 A. George Awad and Lakshmi N.P. Voruganti 17. Quality of Life Outcomes of ECT 321 Peter B. Rosenquist and W. Vaughn McCall 18. Quality of Life in Mental Health Services 333 Sherrill Evans Contents vii 19. Subjective Quality of Life in Relation to Psychiatric Rehabilitation and Daily Life 355 Mona Eklund 20. Cost-Utility Analysis 373 Mojca Z. Dernovsek, Valentina Prevolnik-Rupel and Rok Tavcar Index 385 CONTRIBUTORS Roee Admon, Functional Brain Imaging Unit, Wohl Institute for Advanced Imaging TASMC, Medical Science, Faculty of Medicine, Tel Aviv University, Israel; [email protected] A. George Awad, MB, Bch, PhD, FRCPC, Professor Emeritus, Department of Psychiatry and the Institute of Medical Science University of Toronto, Chief of Psychiatry, Humber River Regional Hospital, Canada; [email protected] Maria-Teresa Bascarán, MD, Department of Psychiatry, University of Oviedo, Spain; [email protected] Andreas Bechdolf, MD, Consultant Psychiatrist, Cologne Early Recognition and Intervention Centre for mental crisis – FETZ, Department of Psychiatry and Psychotherapy, University of Cologne, Kerpenerstr. 6250937 Köln, Germany; [email protected] Marcelo T. Berlim, MD, MSc, Depressive Disorders Program and McGill Group for Suicide Studies, Douglas Hospital Research Centre, McGill University, Montréal, Quebec, Canada; [email protected] Julio Bobes, MD, PhD, Department of Psychiatry, University of Oviedo, Spain; [email protected] Maria-Teresa Bobes-Bascarán, PhD, Department of Psychiatry, University of Oviedo, Spain; [email protected] Manuel Bousoño, MD, PhD, Department of Psychiatry, University of Oviedo, Spain; [email protected] Monika Bullinger, MD, Professor, University Medical Centre of Hamburg Eppendorf Institute and Policlinic for Medical Psychology, Hamburg, Germany; [email protected] ix x Contributors Mojca Z. Dernovsek, MD, PhD, Assistant Professor, University Psychiatric Hospital, Institute of Public Health of Republic of Slovenia, Ljubljana, Slovenia; [email protected] MonaEklund,Professor,DepartmentofHealthSciences,DivisionofOccupational Therapy, Lund University, Sweden; [email protected] Sherrill Evans PhD, Senior Lecturer in Social Work and Social Care; Centre for Carework Research, Department of Applied Social Sciences, University of Wales, Swansea; [email protected] Marcelo P.A. Fleck, MD, PhD, Professor, Department of Psychiatry and Forensic Medicine; Head, Mood Disorders Program Hospital de Clínicas de Porto Alegre, Brazil M.-P. García-Portilla, MD, PhD, Associate Professor, Department of Psychiatry, University of Oviedo, Spain; [email protected] Anatoly Gibel, MD, Senior Psychiatrists, Acute Department, Sha’ar Menashe Mental Health Center, Israel; [email protected] Graeme Hawthorne, A/Professor, Department of Psychiatry, The University of Melbourne, Australia; [email protected] Talma Hendler MD, PhD, Senior lecturer, Psychology Department and Faculty of Medicine, Tel Aviv University, Director, Functional Brain Imaging Unit, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Israel; [email protected] Joachim Klosterkötter, MD, Professor of Psychiatry, Chair, Director, Department of Psychiatry, and Psychotherapy, University of Cologne, Kerpenerstr. 6250937 Köln, Germany; [email protected] Margaret A. Koury, MS, Research Project Assistant, Cedars-Sinai Health System, Department of Psychiatry, Los Angeles, USA; [email protected] Raymond W. Lam, Professor and Head, Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia, Vancouver, Canada Shira Louria, MSW, Research assistant at the Roudebush VA Medical Center and a doctoral candidate at the University of Indianapolis, School of Psychological Science, USA Contributors xi Paul H. Lysaker, Ph.D., Staff Psychologist at the Roudebush VA Medical Center and Assistant Professor of Clinical Psychology in the Department of Psychiatry at theIndianaUniversitySchoolofMedicine,DepartmentofPsychiatry,Indianapolis, USA; [email protected] Marianna Mazza, MD, PhD, Institute of Psychiatry, Catholic University of Sacred Heart, Rome, Italy; [email protected] or marianna.mazza@ rm.unicatt.it Salvatore Mazza, MD, Professor and Head, Neurophysiopathology Unit, Department of Neurosciences, Catholic University of Sacred Heart, Rome, Italy W. Vaughn McCall, MD, MPH, Professor and Chair, Wake Forest University School of Medicine, Medical Center Blvd., USA Erin E. Michalak, PhD, Assistant Professor, MSFHR Scholar & CIHR New Investigator, Mood Disorders Centre, Department of Psychiatry, University of British Columbia, Vancouver, Canada; [email protected] Greg Murray, PhD, Senior Lecturer and Clinical Psychologist, Faculty of Life and Social Sciences, Swinburne University of Technology, Hawthorn, Australia; [email protected] Dieter Naber, MD, Professor, University Medical Centre of Hamburg Eppendorf, Department of Psychiatry, Centre of Psychosocial Medicine, Hamburg, Germany DavidPapo,FunctionalBrainImagingUnit,WohlInstituteforAdvancedImaging TASMC, Israel; [email protected] Valentina Prevolnik-Rupel, BA, MSc, Ministry of Health of Republic of Slovenia, Ljubljana, Slovenia Ralf Pukrop, PhD, ScMD, Associate Professor, Section of Experimental and Clinical Psychology, Department of Psychiatry and Psychotherapy, University of Cologne, Kerpenerstr. 6250937 Köln Germany; [email protected] Mark Hyman Rapaport, MD, Chairman, Department of Psychiatry, The Polier Endowed Chair in Schizophrenia, and Related Disorders, Cedars-Sinai Medical Center, Department of Psychiatry, Los Angeles, USA; [email protected] Michael S. Ritsner, MD, PhD, Associate Professor, Department of Psychiatry, The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology; and Director, Acute Department, Sha’ar Menashe Mental Health Center, Israel; [email protected]

Description:
A fascinating and worthy text that presents new insights into a hugely important area of mental health. Health-related quality of life (HRQL) impairment is a core domain of prevalent mental disorders such as schizophrenia, schizoaffective, mood and anxiety disorders. The authors present a new concep
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.